Research programme: monoclonal antibodies - Immusol/Medarex
Alternative Names: Monoclonal antibodies research programme - Immusol/MedarexLatest Information Update: 03 May 2007
At a glance
- Originator Immusol; Medarex
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 03 May 2007 No development reported - Preclinical for Undefined indication in USA (unspecified route)
- 29 Jun 2005 This programme is still in active development
- 03 Feb 2003 This programme is still in active development